Document Detail


Injectable administration privileges among pharmacists in the United States.
MedLine Citation:
PMID:  23135568     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Purpose Privileges for administering nonvaccine injectable medications among pharmacists in the United States were assessed. Methods An e-mail inquiry on specific protocols for the administration of injectables was sent to the state boards of pharmacy (BOPs) for all 50 states and the District of Columbia that had a valid e-mail address listed on the National Association of Boards of Pharmacy website. Respondents were encouraged to include in their response a link to state regulations so that information from the BOP laws on privileges for administering injectables could be closely reviewed. State guidelines were reviewed online for all BOPs that did not respond to the first e-mail in order to complete the study. A follow-up e-mail was sent only to those respondents whose states granted pharmacists privileges for administering nonvaccine injectables in order to clarify the specific drugs allowed to be injected by pharmacists. Results Responses received included either links to state regulations or explicit statements of the rules regarding pharmacists' injectable privileges. A total of 21 states currently grant pharmacists articulate written information or rules pertaining to the privilege of administering nonvaccine injectable products. Authority is provided through collaborative practice agreements for most states. Products administered by pharmacists vary by state. Conclusion Pharmacists in 21 states were found to have privileges for administering injectable medications other than vaccines. Pharmacists were authorized to administer these drugs through completion of training approved by the Accreditation Council for Pharmacy Education, collaborative practice agreements, valid prescription orders, board certification, or other broad privileges as specified in state regulations. Am J Health-Syst Pharm. 2012; 69:2002-5.
Authors:
Valerie Oji; Yolanda McKoy-Beach; Tiffany Pagan; Barbara Matike; Oluwaranti Akiyode
Related Documents :
24804728 - Not only a clinical nightmare: amniotic fluid embolism in court.
23830758 - International accreditation of ambulatory surgical centers and medical tourism.
23920778 - Design of the asthma treat smart system in a pediatric institution.
25006138 - Early experiences with big data at an academic medical center.
15595468 - Comparison of 23 gauge and 25 gauge anterior capsulotomy forceps.
24367898 - The effect of serious mental illness on the risk of rehospitalization among patients wi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists     Volume:  69     ISSN:  1535-2900     ISO Abbreviation:  Am J Health Syst Pharm     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9503023     Medline TA:  Am J Health Syst Pharm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2002-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Extended stability of intravenous acetaminophen in syringes and opened vials.
Next Document:  California court's decision regarding a physician's petition for reinstatement of his medical licens...